M. Blake Ingle
Chairman at Alerion Biomedical, Inc.
Profile
Dr. Ingle was formerly CEO of IMCERA Group, a Fortune 250 healthcare company.
He has over thirty years of healthcare experience, including CEO of Canji, a biotech company that was sold to Schering-Plough in a successful transition for its venture capital investors.
Dr. Ingle also serves on the Board of Directors of Vical, Dendreon Corporation, Cengent Therapeutics, Alerion, Targeted Molecules Corp., INEX Pharmaceuticals, and serves as Strategic Advisor for Quorex Pharmaceuticals, and is a recent past Chairman of the Burnham Institute (formerly the La Jolla Cancer Research Foundation).
Dr. Ingle received a BS degree from Lewis University and an MS degree and a PhD from Colorado State University.
M. Blake Ingle active positions
Companies | Position | Start |
---|---|---|
Alerion Biomedical, Inc.
Alerion Biomedical, Inc. Medical SpecialtiesHealth Technology Alerion Biomedical, Inc. manufactures novel technologies for improving detection. It also manufactures biomarkers and contrast media for preclinical and clinical imaging devices. The company is headquartered in San Diego, CA. | Chairman | - |
Former positions of M. Blake Ingle
Companies | Position | End |
---|---|---|
DENDREON CORPORATION | Director/Board Member | 2009-06-09 |
BRIDGETECH HOLDINGS INTERNATIONAL I(NDA) | Director/Board Member | 2008-04-13 |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | President | 1996-01-31 |
Mallinckrodt, Inc.(Old)
Mallinckrodt, Inc.(Old) Medical SpecialtiesHealth Technology Mallinckrodt, Inc. developed manufactured and marketed medical products for hospitals. It provided specialty healthcare products for diagnostic imaging, respiratory care and pain relief. The firm sold its products to hospitals, alternate care sites, drug manufacturers and clinical laboratories. The company was founded in 1867 and was headquartered in Hazelwood, MO. | President | 1992-12-31 |
Corvas International, Inc. | Chairman | - |
Training of M. Blake Ingle
Lewis University | Undergraduate Degree |
Colorado State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 9 |
---|---|
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
Targeted Molecules Corp.
Targeted Molecules Corp. Miscellaneous Commercial ServicesCommercial Services Targeted Molecules Corp. is a biopharmaceutical company. It discovers and commercializes targeted drug therapies for a broad range of ailments including cancer and diseases of the central nervous system (CNS). Targeted Molecules was founded in 2000 and is located in San Diego, CA. | Commercial Services |
IngleWood Ventures
IngleWood Ventures Investment ManagersFinance Founded in 1999, IngleWood Ventures is a venture capital firm located in San Diego, California. | Finance |
Alerion Biomedical, Inc.
Alerion Biomedical, Inc. Medical SpecialtiesHealth Technology Alerion Biomedical, Inc. manufactures novel technologies for improving detection. It also manufactures biomarkers and contrast media for preclinical and clinical imaging devices. The company is headquartered in San Diego, CA. | Health Technology |
Corvas International, Inc. | Health Technology |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Health Services |
Mallinckrodt, Inc.(Old)
Mallinckrodt, Inc.(Old) Medical SpecialtiesHealth Technology Mallinckrodt, Inc. developed manufactured and marketed medical products for hospitals. It provided specialty healthcare products for diagnostic imaging, respiratory care and pain relief. The firm sold its products to hospitals, alternate care sites, drug manufacturers and clinical laboratories. The company was founded in 1867 and was headquartered in Hazelwood, MO. | Health Technology |
Global Seafood Holdings Corp.
Global Seafood Holdings Corp. Financial ConglomeratesFinance Global Seafood Holdings Corp. operates as a development stage company. The firm focuses its preliminary mergers and acquisition activities on the business opportunities with established business entities for the merger of a target business with its company. The company was founded by Herbert Wong and Scott D. Landow on June 4, 1991 and is headquartered in San Diego, CA. | Finance |
- Stock Market
- Insiders
- M. Blake Ingle